Gene · 122876
Papers2,598
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,598
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties. | Sci Rep | 2024 | 39138277 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers. | Sci Rep | 2024 | 39127727 | PubTator, text mining | PubMed |
| The 26 S proteasome in Entamoeba histolytica: divergence of the substrate binding pockets from host proteasomes. | BMC Res Notes | 2024 | 39095914 | PubTator, text mining | PubMed |
| Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria. | Cell Chem Biol | 2024 | 39084225 | PubTator, text mining | PubMed |
| Peptidic Boronic Acid Plasmodium falciparum SUB1 Inhibitors with Improved Selectivity over Human Proteasome. | J Med Chem | 2024 | 39051854 | PubTator, text mining | PubMed |
| [Establishment of a stable THP-1 cell line expressing PSMB9-eGFP-His protein and detection of immunoproteasome activity]. | Sheng Wu Gong Cheng Xue Bao | 2024 | 39044591 | PubTator, text mining | PubMed |
| Bi-level optimization of shared manufacturing service composition based on improved NSGA-II. | PLoS One | 2024 | 38885266 | PubTator, text mining | PubMed |
| Modulation of proteasome subunit selectivity of syringolins. | Bioorg Med Chem | 2024 | 38704960 | PubTator, text mining | PubMed |
| The Role of Climatic, Environmental and Socioeconomic Factors in the Natural Movement of Urban Populations in Kazakhstan, 2012-2020: An Analysis from a Middle-Income Country in Central Asia. | Int J Environ Res Public Health | 2024 | 38673328 | PubTator, text mining | PubMed |
| Mechanism of autocatalytic activation during proteasome assembly. | Nat Struct Mol Biol | 2024 | 38600323 | PubTator, text mining | PubMed |
| The relations between growth mindset, motivational beliefs, and career interest in math intensive fields in informal STEM youth programs. | PLoS One | 2024 | 38593114 | PubTator, text mining | PubMed |
| Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. | Pathol Oncol Res | 2024 | 38312516 | PubTator, text mining | PubMed |
| Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells. | J Transl Med | 2024 | 38308299 | PubTator, text mining | PubMed |
| Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. | Cell Death Discov | 2024 | 38286854 | PubTator, text mining | PubMed |
| Asymmetric effects of foreign direct investment and globalization on ecological footprint in Indonesia. | PLoS One | 2024 | 38277414 | PubTator, text mining | PubMed |
| Differentiated genomic footprints suggest isolation and long-distance migration of Hmong-Mien populations. | BMC Biol | 2024 | 38273256 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. | Mol Cancer | 2024 | 38243280 | PubTator, text mining | PubMed |
| RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease. | Heliyon | 2024 | 38187218 | PubTator, text mining | PubMed |
| Decrypting Allostery in Membrane-Bound K-Ras4B Using Complementary In Silico Approaches Based on Unbiased Molecular Dynamics Simulations. | J Am Chem Soc | 2024 | 38116743 | PubTator, text mining | PubMed |
| Structural insights into the complex of oncogenic KRas4BG12V and Rgl2, a RalA/B activator. | Life Sci Alliance | 2024 | 37833074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/122876/papers?page=4